ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment
January 14, 2020Neurelis, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizure
Pharma Sources Insight January 2025
